These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15579039)

  • 1. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery.
    Lanza GM; Winter P; Caruthers S; Schmeider A; Crowder K; Morawski A; Zhang H; Scott MJ; Wickline SA
    Curr Pharm Biotechnol; 2004 Dec; 5(6):495-507. PubMed ID: 15579039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated MR contrast agents.
    Lowe MP
    Curr Pharm Biotechnol; 2004 Dec; 5(6):519-28. PubMed ID: 15579041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates.
    Aime S; Barge A; Cabella C; Crich SG; Gianolio E
    Curr Pharm Biotechnol; 2004 Dec; 5(6):509-18. PubMed ID: 15579040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese enhanced magnetic resonance imaging.
    Lee JH; Koretsky AP
    Curr Pharm Biotechnol; 2004 Dec; 5(6):529-37. PubMed ID: 15579042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimer-based nanosized MRI contrast agents.
    Kobayashi H; Brechbiel MW
    Curr Pharm Biotechnol; 2004 Dec; 5(6):539-49. PubMed ID: 15579043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ.
    Ho C; Hitchens TK
    Curr Pharm Biotechnol; 2004 Dec; 5(6):551-66. PubMed ID: 15579044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of cell surface receptors using targeted contrast agents.
    Artemov D; Bhujwalla ZM; Bulte JW
    Curr Pharm Biotechnol; 2004 Dec; 5(6):485-94. PubMed ID: 15579038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring cell therapy using iron oxide MR contrast agents.
    Bulte JW; Kraitchman DL
    Curr Pharm Biotechnol; 2004 Dec; 5(6):567-84. PubMed ID: 15579045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible target specific molecular imaging with ultrasound contrast agents].
    Mäurer M; Linker R; Reinhardt M; Hauff P
    Radiologe; 2005 Jun; 45(6):560-8. PubMed ID: 15912322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted magnetic resonance imaging contrast agents.
    Caruthers SD; Winter PM; Wickline SA; Lanza GM
    Methods Mol Med; 2006; 124():387-400. PubMed ID: 16506431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe.
    Tsai CP; Hung Y; Chou YH; Huang DM; Hsiao JK; Chang C; Chen YC; Mou CY
    Small; 2008 Feb; 4(2):186-91. PubMed ID: 18205156
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold nanoshell bioconjugates for molecular imaging in living cells.
    Loo C; Hirsch L; Lee MH; Chang E; West J; Halas N; Drezek R
    Opt Lett; 2005 May; 30(9):1012-4. PubMed ID: 15906987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron oxide MR contrast agents for molecular and cellular imaging.
    Bulte JW; Kraitchman DL
    NMR Biomed; 2004 Nov; 17(7):484-99. PubMed ID: 15526347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of image heterogeneity using 2D Minkowski functionals increases the sensitivity of detection of a targeted MRI contrast agent.
    Canuto HC; McLachlan C; Kettunen MI; Velic M; Krishnan AS; Neves AA; de Backer M; Hu DE; Hobson MP; Brindle KM
    Magn Reson Med; 2009 May; 61(5):1218-24. PubMed ID: 19253374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.
    Neubauer AM; Sim H; Winter PM; Caruthers SD; Williams TA; Robertson JD; Sept D; Lanza GM; Wickline SA
    Magn Reson Med; 2008 Dec; 60(6):1353-61. PubMed ID: 19025903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical application of functionalized magnetic nanoparticles.
    Ito A; Shinkai M; Honda H; Kobayashi T
    J Biosci Bioeng; 2005 Jul; 100(1):1-11. PubMed ID: 16233845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance molecular imaging with nanoparticles.
    Lanza GM; Winter PM; Caruthers SD; Morawski AM; Schmieder AH; Crowder KC; Wickline SA
    J Nucl Cardiol; 2004; 11(6):733-43. PubMed ID: 15592197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging concepts in molecular MRI.
    Sosnovik DE; Weissleder R
    Curr Opin Biotechnol; 2007 Feb; 18(1):4-10. PubMed ID: 17126545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J; Ochoa E; Misselwitz B; Yang D; El Naqa I; Woodard PK; Abendschein D
    Invest Radiol; 2008 Jan; 43(1):49-55. PubMed ID: 18097277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.